Sertraline Included in β-ciclodextrin does not Induce a Tolerogenic Profile in Monocyted-Derived Dendritic Cells
PDF (Spanish)
XML JATS (Spanish)

Keywords

dendritic cells, sertraline, β-cyclodextrin

How to Cite

Sertraline Included in β-ciclodextrin does not Induce a Tolerogenic Profile in Monocyted-Derived Dendritic Cells. (2017). Universitas Medica, 57(4), 438-449. https://doi.org/10.11144/Javeriana.umed57-4.sert
Almetrics
 
Dimensions
 

Google Scholar
 
Search GoogleScholar

Abstract

Objective: To evaluate the immunomodulatory effect of sertraline (SRT) and sertraline included in β-cyclodextrin (LF) in human dendritic cells (DCs) generated in vitro from monocytes on phenotype markers and cytokine production. Materials and Methods: CD14 + monocytes from peripheral blood mononuclear cells were isolated and differentiated to DCs. DCs were subsequently pretreated with LF or SRT for one hour. Finally DCs were matured with lipopolysaccharide (LPS) for 24 hours and the CDs phenotype and the levels of cytokines in the culture supernatants were analyzed. Results: No change on the phenotype of the DCs matured with LPS in the absence or presence of the SRT was observed. Likewise, there was no variation in cytokine production. Conclusion: SRT or not including β-cyclodextrin does not affect the phenotype and secretion of LPS-treated DCs.

PDF (Spanish)
XML JATS (Spanish)

Nouws HPA, Delerue-Matos C, Barros

AA, Rodrigues JA. Electroanalytical

study of the antidepressant sertraline. J

Pharmaceut Biomed. 2005;39:290-93.

Passos JJ, De Sousa FB, Lula IS, Barreto

EA, Lopes JF, De Almeida WB, Sinisterra

RD. Multi-equilibrium system based

on sertraline and β-cyclodextrin supramolecular

complex in aqueous solution.

Int J Pharm. 2011;421(1):24-33. doi:

1016/j.ijpharm.2011.09.026

Davis ME, Brewster ME. Cyclodextrin-

based pharmaceutics: past, present

and future. Nat Rev Drug Discov.

;3:1023-35.

Furtado M, Katzman MA. Examining the

role of neuroinflammation in major depression.

Psychiat Res. 2015;229:27-36.

Lesch KP. Gene-environment interaction

and the genetics of depression. J Psychiat

Neurosci. 2004;29:174.

Felger JC, Lotrich FE. Inflammatory cytokines

in depression: neurobiological

mechanisms and therapeutic implications.

Neuroscience. 2013;246:199-229.

Dowlati Y, Herrmann N, Swardfager

W, Liu H, Sham L, Reim EK, Lanctôt

KL. A meta-analysis of cytokines

in major depression. Biol Psychiatry.

;67(5):446-57. doi: 10.1016/j.biopsych.

09.033

Branco-de-Almeida LS, Franco GC,

Castro ML, Dos Santos JG, Anbinder

AL, Cortelli SC, et al. Fluoxetine inhibits

inflammatory response and bone loss in

a rat model of ligature-induced periodontitis.

J Periodontol. 2012;83(5):664-71.

doi: 10.1902/jop.2011

Tynan RJ, Weidenhofer J, Hinwood M,

Cairns MJ, Day TA, Walker FR. A comparative

examination of the anti-inflammatory

effects of SSRI and SNRI antidepressants

on LPS stimulated microglia. Brain Behav

Immun. 2012;26:469-79. doi: 10.1016/j.

bbi.2011.12.011

Daniele S, Da Pozzo E, Zappelli E, Martini

C. Trazodone treatment protects neuronal-

like cells from inflammatory insult

by inhibiting NF-KB, p38 and JNK. Cell

Signal. 2015;27:1609-29.

Franco R, Pacheco R, Lluis C, Ahern GP,

O´Connell PJ. The emergence of neurotransmitters

as immune modulators.

Trends Immunol. 2007;28:400-7.

Mössner R, Lesch K-P. Role of serotonin

in the immune system and in neuroimmune

interactions. Brain Behav Immun.

;12:249-71.

O’Connell PJ, Wang X, Leon-Ponte M,

Griffiths C, Pingle SC, Ahern GP. A novel

form of immune signaling revealed by

transmission of the inflammatory mediator

serotonin between dendritic cells and

T cells. Blood. 2006;107(3):1010-7.

Idzko M, Panther E, Stratz C, Müller T,

Bayer H, Zissel G, et al. The serotoninergic

receptors of human dendritic cells:

identification and coupling to cytokine

release. J Immunol. 2004;172(10):6011-

Muller T, Dürk T, Blumenthal B, Grimm

M, Cicko S, Panther E, et al. 5-hydroxytryptamine

modulates migration, cytokine

and chemokine release and T-cell

priming capacity of dendritic cells in vitro

and in vivo. PLoS One. 2009;4(7):e6453.

doi: 10.1371/journal.pone.0006453

Katoh N, Soga F, Nara T, Tamagawa-Mineoka

R, Nin M, Kotani H, et al. Effect of

serotonin on the differentiation of human

monocytes into dendritic cells. Clin Exp

Immunol. 2006;146(2):354-61.

Ahern GP. 5-HT and the immune system.

Curr Opin Pharmacol. 2011;11:29-33.

Branco-de-Almeida LS, Kajiya M, Cardoso

CR, Silva MJ, Ohta K, Rosalen PL,

et al. Selective serotonin reuptake inhibitors

attenuate the antigen presentation

from dendritic cells to effector T lymphocytes.

FEMS Immunol Med Microbiol.

;62(3):283-94. doi: 10.1111/j.1574-

X.2011.00816.x

Nikolic T, Roep BO. Regulatory multitasking

of tolerogenic dendritic cellslessons

taken from vitamin d3-treated

tolerogenic dendritic cells. Front Immunol.

;4:113. doi: 10.3389/

fimmu.2013.00113

Steinman RM. Dendritic cells: understanding

immunogenicity. Eur J Immunol.

;37:S53-60.

Onishi M, Ozasa K, Kobiyama K,

Ohata K, Kitano M, Taniguchi K et al.

Hydroxypropyl-β-cyclodextrin spikes

local inflammation that induces th2 cell

and t follicular helper cell responses to

the coadministered antigen. J Immunol.

;194(6):2673-82. doi: 10.4049/jimmunol.

Lee JS, Jung ID, Lee CM, Noh KT, Park

JW, Son KH, et al. Venlafaxine inhibits

the development and differentiation of

dendritic cells through the regulation of

P-glycoprotein. Int Immunopharmacol.

;11(9):1348-57. doi: 10.1016/j.intimp.

04.019

This journal is registered under a Creative Commons Attribution 4.0 International Public License. Thus, this work may be reproduced, distributed, and publicly shared in digital format, as long as the names of the authors and Pontificia Universidad Javeriana are acknowledged. Others are allowed to quote, adapt, transform, auto-archive, republish, and create based on this material, for any purpose (even commercial ones), provided the authorship is duly acknowledged, a link to the original work is provided, and it is specified if changes have been made. Pontificia Universidad Javeriana does not hold the rights of published works and the authors are solely responsible for the contents of their works; they keep the moral, intellectual, privacy, and publicity rights.

Approving the intervention of the work (review, copy-editing, translation, layout) and the following outreach, are granted through an use license and not through an assignment of rights. This means the journal and Pontificia Universidad Javeriana cannot be held responsible for any ethical malpractice by the authors. As a consequence of the protection granted by the use license, the journal is not required to publish recantations or modify information already published, unless the errata stems from the editorial management process. Publishing contents in this journal does not generate royalties for contributors.